Abstract To surpass challenges with traditional approaches to treat Rheumatoid arthritis (RA), an improved understanding of molecular-level pathogenesis brought forth targeted therapy with biologics as a great promise in halting the progression of RA
How a First-in-Human Trial Works First-in-Human trials are generally conducted in highly controlled clinical environments such as specialist clinics or hospital settings designed to ensure continuous participant monitoring and rapid intervention if necessary
Glutathione breaks down wastes, toxins, and heavy metals into less harmful compounds
Do not wait for routine labs Fever, spreading redness, severe wound pain, jaundice, allergic symptoms, chest pain, or one-sided leg swelling needs medical review
The main challenge with oral reduced glutathione (GSH) is its low absorption rate
The meeting lasted over an hour where a whole range of biochemical and medical evidence was discussed